Efficacy and Safety of Fingolimod in an Unselected Patient Population.

Efficacy and Safety of Fingolimod in an Unselected Patient Population.

Fingolimod is a first in class oral compound approved for the treatment of relapsing-remitting multiple sclerosis (RR-MS). The aim of this study was to evaluate clinical and neuroradiological responses to fingolimod as well as the safety and tolerability in RR-MS patients in clinical practice. In ad...

Full description

Bibliographic Details
Main Authors: Maria Rasenack, Jonathan Rychen, Michaela Andelova, Yvonne Naegelin, Christoph Stippich, Ludwig Kappos, Raija L P Lindberg, Till Sprenger, Tobias Derfuss
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4703383?pdf=render

Internet

http://europepmc.org/articles/PMC4703383?pdf=render

Similar Items